Recall Jujitsu: Can FDA’s Alert Shortcomings Help It Politically?
Executive Summary
Research in the Archives of Internal Medicine suggests FDA doesn’t always notify the public about serious drug recalls as well as it should. But the agency is using the findings to emphasize how much firms could be doing as the debate on the design of a distribution tracking system swirls on Capitol Hill.